The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure
Movement Disorders · 2023-06 · 38 (6) · 1089-1093
DOI: 10.1002/mds.29403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 12.04.2023. Verfasst von Laura Pérez-Carbonell und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sleep Disorders Centre, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. Hauptthemen laut MEDLINE: REM Sleep Behavior Disorder, Parkinson Disease, Synucleinopathies. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Parkinson's UK, Wellcome Trust, Barts Charity.
Abstract (Originalsprache)
Background
Isolated rapid eye movement sleep behavior disorder (iRBD) is associated with an increased risk of Parkinson's disease and other synucleinopathies. There is no consensus about disclosure of this risk to patients with iRBD.
Objective
The objective of our study was to assess the experiences of risk disclosure in a group of patients with iRBD and their views on what, when, and how this should be done.
Methods
A survey was administered to patients with iRBD to explore their experiences and views on risk disclosure.
Results
Thirty‐one patients with iRBD (28 males; mean age, 70 [SD 8.7] years; mean disease duration, 8.7 [SD 6.4] years) were included. A third reported they had not been informed about the link between iRBD and other conditions by clinicians at diagnosis, but 90% would have liked to have received prognostic information, and 60% indicated that this should happen at the point that iRBD was diagnosed. Most participants wanted this information to come from the clinician diagnosing and treating iRBD (90.3%). Almost three‐quarters (72.2%) had searched for this information online.
Conclusions
Patients with iRBD mostly wished to have received information regarding the potential implications of iRBD when the diagnosis was made. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sleep Disorders Centre, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
- Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.
- Department of Clinical and Movement Neuroscience, UCL Institute of Neurology, London, United Kingdom.
ORCID-Profile: Laura Pérez-Carbonell, Cristina Simonet, Anette Schrag, Alastair J Noyce
Förderung
- Parkinson's UK
- Wellcome Trust
- Barts Charity
Zitieren
APA
Pérez-Carbonell, L., Simonet, C., Chohan, H., Gill, A., Leschziner, G., Schrag, A., & Noyce, A. J. (2023). The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure. Movement Disorders, 38(6), 1089-1093. https://doi.org/10.1002/mds.29403
Vancouver
Pérez-Carbonell L, Simonet C, Chohan H, Gill A, Leschziner G, Schrag A, et al. The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure. Movement Disorders. 2023;38(6):1089-1093. doi:10.1002/mds.29403
BibTeX
@article{PrezCarbonell2023,
author = {Pérez-Carbonell, Laura and Simonet, Cristina and Chohan, Harneek and Gill, Aneet and Leschziner, Guy and Schrag, Anette and Noyce, Alastair J},
title = {The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure},
journal = {Movement Disorders},
year = {2023},
volume = {38},
number = {6},
pages = {1089--1093},
doi = {10.1002/mds.29403}
}
EUVIMED